Clinical characteristics of synthetic cannabinoid-induced psychosis in relation to schizophrenia: a single-center cross-sectional analysis of concurrently hospitalized patients

References

• FattoreLSynthetic cannabinoids-further evidence supporting the relationship between cannabinoids and psychosisBiol Psychiatry201679753954826970364
   PubMed Web of Science ®Google Scholar
• CohenJMorrisonSGreenbergJSaidinejadMClinical presentation of intoxication due to synthetic cannabinoidsPediatrics20121294e1064e106722430444
   PubMed Web of Science ®Google Scholar
• HarrisCRBrownASynthetic cannabinoid intoxication: a case series and reviewJ Emerg Med201344236036622989695
   PubMed Web of Science ®Google Scholar
• GurdalFAsirdizerMAkerRGReview of detection frequency and type of synthetic cannabinoids in herbal compounds analyzed by Istanbul Narcotic Department of the Council of Forensic Medicine, TurkeyJ Forensic Leg Med201320666767223910858
   PubMed Web of Science ®Google Scholar
• BesliGEIkizMAYildirimSSaltikSSynthetic cannabinoid abuse in adolescents: a case seriesJ Emerg Med201549564465026293411
   PubMed Web of Science ®Google Scholar
• CobanMThe rise of synthetic marijuana in Turkey: the Bonzai phenomenon of the 2010sAddicta Turkish J Addict2014114162
   Google Scholar
• VandreyRDunnKEFryJAGirlingERA survey study to characterize use of spice products (synthetic cannabinoids)Drug Alcohol Depend20121201–323824121835562
   PubMed Web of Science ®Google Scholar
• KucukEKucukIKirazaldiYYA new threat in the emergency department: synthetic cannabinoids (Bonzai, Jamaica)Genel Tıp Derg2015251822
   Google Scholar
• SeyitMOzenMOskayAKadiogluEEffectiveness of the synthetic cannabinoids seminarTurk J Emerg Med20161625759
   PubMed Web of Science ®Google Scholar
• Every-PalmerSSynthetic cannabinoid JWH-018 and psychosis: an explorative studyDrug Alcohol Depend20111172–315215721316162
   PubMed Web of Science ®Google Scholar
• D’SouzaDCSpadernaMAddyPRanganathanMSpicing thing up – what can we learn from synthetic cannabinoids about the link between cannabinoids and psychosisSchizophr Res2014153suppl 1S32
   Web of Science ®Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)Understanding the “Spice” PhenomenonLuxembourgPublications Office of the European Union2009 Available from: http://www.emcdda.europa.eu/Accessed May 24, 2016
   Google Scholar
• SeelyKALapointJMoranJHFattoreLSpice drugs are more than harmless herbal blends: A review of the pharmacology and toxicology of synthetic cannabinoidsProg Neuropsychopharmacol Biol Psychiatry201239223424322561602
   PubMed Web of Science ®Google Scholar
• BaumannMHSolisEJrWattersonLRMarusichJAFantegrossiWEWileyJLBaths salts, spice, and related designer drugs: the science behind the headlinesJ Neurosci20143446151501515825392483
   PubMed Web of Science ®Google Scholar
• van AmsterdamJBruntTvan den BrinkWThe adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effectsJ Psychopharmacol201529325426325586398
   PubMed Web of Science ®Google Scholar
• GluePAl-ShaqsiSHancockDGaleCStrongBSchepLHospitalization associated with use of the synthetic cannabinoid K2N Z Med J20131261377182323831873
   PubMedGoogle Scholar
• MüllerHSperlingWKöhrmannMHuttnerHBKornhuberJMalerJMThe synthetic cannabinoid Spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodesSchizophr Res20101181–330931020056392
   PubMed Web of Science ®Google Scholar
• Every-PalmerSWarning: Legal synthetic cannabinoid receptor agonists such as JWH018 may precipitate psychosis in vulnerable individualsAddiction2010105101859186020840203
   PubMed Web of Science ®Google Scholar
• Van der VeerNFridayJPersistent psychosis following the use of SpiceSchizophr Res20111301–328528621602030
   PubMed Web of Science ®Google Scholar
• CelofigaAKoprivsekJKlavzJUse of synthetic cannabinoids in patients with psychotic disorders: case seriesJ Dual Diagn201410316817325392292
   PubMed Web of Science ®Google Scholar
• SherifMRadhakrishnanRD’SouzaDCRanganathanMHuman laboratory studies on cannabinoids and psychosisBiol Psychiatry201679752653826970363
   PubMed Web of Science ®Google Scholar
• BroydSJvan HellHHBealeCYücelMSolowijNAcute and chronic effects of cannabinoids on human cognition-a systematic reviewBiol Psychiatry201679755756726858214
   PubMed Web of Science ®Google Scholar
• American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders: DSM-5Washington, DCAmerican Psychiatric Publishing2013
   Google Scholar
• OverallJEGorhamDRThe brief psychiatric rating scalePsychol Rep196210799812
   Web of Science ®Google Scholar
• SoykanCInstitutional differences and case typicality as related to diagnosis system severity, prognosis and treatmentAnkaraMaster Thesis, Middle East Technical University1989
   Google Scholar
• KaySRFiszbeinAOplerLAThe positive and negative syndrome scale (PANSS) for schizophreniaSchizophr Bull19871322612763616518
   PubMed Web of Science ®Google Scholar
• KostakogluEABaturSTiryakiAGöğüşAValidity and reliability of Turkish version of the Positive and Negative Syndrome Scale (PANSS)Türk Psikoloji Derg1999142332
   Web of Science ®Google Scholar
• DuboisBSlachevskyALitvanIPillonBThe FAB: A Frontal Assessment Battery at bedsideNeurology200055111621166611113214
   PubMed Web of Science ®Google Scholar
• GüleçHKavakçıÖGüleçMYKüçükalioğluCIPsychometric properties of the Turkish version of the Frontal Assessment Battery in patients with schizophreniaJ Psychiatry Neurol Sci2007203151157
   Google Scholar
• WilliamsBWA structured interview guide for Hamilton Depression Rating ScaleArch Gen Psychiatry19784587427473395203
   PubMed Web of Science ®Google Scholar
• AkdemirAOrselSDagITürkcaparHIscanNOzbayHThe validity, reliability and clinical use of Hamilton depression rating scaleTurk J Psychiatry Psychol Psychopharmacol19964251259
   Google Scholar
• HamiltonMThe assessment of anxiety states by ratingBr J Med Psychol1959321505513638508
   PubMed Web of Science ®Google Scholar
• YaziciMKDemirBTanriverdiNKaraagaogluEYolacPHamilton anxiety rating scale: study of interrater reliability and validity (in Turkish)Turk J Psychiatry19989114117
   Google Scholar
• PapantiDSchifanoFBotteonGSpiceophrenia: a systematic overview of “spice”-related psychopathological issues and a case reportHum Psychopharmacol201328437938923881886
   PubMed Web of Science ®Google Scholar
• WinstockARBarrattMJSynthetic cannabis: a comparison of patterns of use and effect profile with natural cannabis in a large global sampleDrug Alcohol Depend20131311–210611123291209
   PubMed Web of Science ®Google Scholar
• BozkurtMUmutGEvrenCKarabulutVClinical characteristics and laboratory test results of patients admitted to outpatient clinic for synthetic cannabinoid usageJ Psychiatry Neurol Sci201427328334
   Google Scholar
• HurstDLoefflerGMcLayRPsychosis associated with synthetic cannabinoid agonists: a case seriesAm J Psychiatry201116810111921969050
   PubMed Web of Science ®Google Scholar
• MorrisonPDZoisVMcKeownDAThe acute effects of synthetic intravenous Delta 9-tetrahydrocannabinol on psychosis, mood and cognitive functioningPsychol Med200939101607161019335936
   PubMed Web of Science ®Google Scholar
• CastellanosDThorntonGSynthetic cannabinoid use: recognition and managementJ Psychiatry Pract20121828693
   Web of Science ®Google Scholar
• CastanetoMSGorelickDADesrosiersNAHartmanRLPirardSHuestisMASynthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implicationsDrug Alcohol Depend2014144124125220897
   PubMed Web of Science ®Google Scholar
• RadhakrishnanRWilkinsonSTD’SouzaDCGone to pot-a review of the association between cannabis and psychosisFront Psychiatry201455424904437
   PubMed Web of Science ®Google Scholar
• SolowijNMichiePTCannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia?J Psychiatry Neurosci2007321305217245472
   PubMed Web of Science ®Google Scholar
• LorenzettiVSolowijNYücelMThe role of cannabinoids in neuroanatomic alterations in cannabis usersBiol Psychiatry2016797e17e3126858212
   PubMed Web of Science ®Google Scholar
• HeinrichsRWZakzanisKKNeurocognitive deficit in schizophrenia: a quantitative review of the evidenceNeuropsychology19981234264459673998
   PubMed Web of Science ®Google Scholar
• RubinoTParolaroDThe impact of exposure to cannabinoids in adolescence: insights from animal modelsBiol Psychiatry201679757858526344755
   PubMed Web of Science ®Google Scholar
• ThomasSBlissSMalikMSuicidal ideation and self-harm following K2 useJ Okla State Med Assoc20121051143043323304900
   PubMedGoogle Scholar
• BrentsLKPratherPLThe K2/Spice phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense productsDrug Metab Rev2014461728524063277
   PubMed Web of Science ®Google Scholar